True or False. Click through the images to learn more about exome testing and Patient for Life™ at Ambry.

Ambry invites you to check out the Gene Scene! Each week, we will explore a gene from the ACMG Secondary Findings list—genes identified by the American College of Medical Genetics and Genomics as having clear, actionable health implications. These genes are included because

Join us for a webinar Wednesday, July 23, at 11 am PDT.

At your family reunions this month, don’t be scared to talk about health! We've gathered some easy ways to start the conversation for you.

Genetic testing isn’t a one-time assessment—our understanding of DNA evolves as science advances. Ambry’s Patient for Life™ program keeps your patients’ results up to date by automatically reanalyzing eligible tests and notifying you of important changes. No retesting needed.

The Ambry CARE Program® has been a crucial digital partner for Lisa McGuire and HCA Ocala. She attributes the success of CARE in part to employee education, helping providers and staff become true champions who believe in the "Why" behind high-risk patient identification. Read.

Over the years, +RNAinsight® has transformed how we interpret hereditary cancer risk (. In just the first year alone, RNA evidence impacted the results of over 26,000 individuals. Thousands of reclassifications were made possible by insights from just a

Today is Gastrointestinal Stromal Tumor (GIST) awareness day. This cancer forms as a growth of cells on the walls of the digestive track. Individuals with a GIST may have no symptoms, especially if the tumor is smaller. These tumors are slow-growing, so it generally takes time

Find out why Nurse Navigator Adrianne Alexander called Ambry when they needed a lab and technology partner to build, then expand a high-risk program. #genetictesting #CARE

No clichés—just faster, smarter care with Progeny. Trusted by genetics teams for almost 30 years. Learn more at

Join us for a webinar Thursday, July 10 at 11 am PDT:

Precision Medicine Online talked to Ambry's Heather Fecteau about how the Ambry CARE Program® succeeds in helping genetic counselors and non-genetic counselor providers to identify high risk patients. Read the article.

Ambry is dedicated to expanding our knowledge of gene-disease relationships to ensure our panels are based on the most accurate and clinically actionable data. Explore the importance in this new study published in Genome Medicine. #AmbryKnowsGenes #VUS.

No clichés—just clarity. Ready to make high-risk workflows routine? Visit

As we conclude National Cancer Survivors Month, we reflect on on the importance of hereditary cancer testing. The stories of the survivors we've worked with challenge us to keep improving. Ambry stands with cancer survivors! Thank you for letting us be a part of your cancer

Rob Pilarski, MS, LCGC, explains the significance of a new study published in the Journal of the National Comprehensive Cancer Network validating The CARE Program®'s effectiveness in identifying high-risk patients who qualify for hereditary cancer testing based on national

The Ambry CARE Program® has been validated for accuracy in identifying high-risk patients for #hereditarycancertesting in a new study published in the Journal of the National Comprehensive Cancer Network. Read the press release. #CARE

The American Academy of Pediatrics has just released guidelines ( endorsing exome and genome sequencing as first-tier tests for children with intellectual disability and global developmental delay. Ambry applauds this important milestone. For families

Did you know 1 in 4 OB/GYN patients meet guidelines for hereditary cancer testing? These screenings can save lives by identifying risks early. Learn how OB/GYNs like Dr. Jacobs are making a difference with comprehensive genetic screening. 🌊Dive in:

LGBTQ+ individuals may experience a higher risk of cancer compared to their heterosexual and cisgender counterparts. This is due to a complex interplay of factors, including higher rates of cancer-related risk factors like smoking and alcohol consumption, barriers to healthcare,